| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4561300
Max Phase: Preclinical
Molecular Formula: C96H154O43
Molecular Weight: 1996.25
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: C=C[C@@](C)(O)CC/C=C(\C)C(=O)O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@](C)(C=C)CCCC(C)C(=O)O[C@H]2C[C@]3(C(=O)O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H](C)[C@H](O[C@@H]5O[C@@H](CO)[C@H](O)[C@H]5O)[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@H]4O)CC[C@]4(C)C(=CC[C@@H]5[C@@]6(C)CC[C@H](O[C@@H]7O[C@H](CO[C@@H]8O[C@H](C)[C@H](O)[C@H](O)[C@H]8O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O)[C@@H](O)[C@H](O)[C@H]7O)C(C)(C)[C@@H]6CC[C@]54C)[C@@H]3CC2(C)C)O[C@@H]1C
Standard InChI: InChI=1S/C96H154O43/c1-17-91(12,121)27-19-21-41(4)79(119)133-73-43(6)126-85(71(116)66(73)111)139-92(13,18-2)28-20-22-40(3)78(118)131-55-34-96(88(120)138-87-77(65(110)59(104)49(36-98)129-87)137-84-72(117)75(135-83-70(115)62(107)58(103)48(35-97)127-83)74(44(7)125-84)134-82-68(113)60(105)50(37-99)128-82)32-31-94(15)45(46(96)33-89(55,8)9)23-24-53-93(14)29-26-54(90(10,11)52(93)25-30-95(53,94)16)132-81-69(114)63(108)61(106)51(130-81)39-123-86-76(64(109)56(101)42(5)124-86)136-80-67(112)57(102)47(100)38-122-80/h17-18,21,23,40,42-44,46-77,80-87,97-117,121H,1-2,19-20,22,24-39H2,3-16H3/b41-21+/t40?,42-,43-,44+,46+,47-,48-,49-,50+,51-,52+,53-,54+,55+,56+,57+,58-,59-,60+,61-,62+,63+,64+,65+,66-,67-,68-,69-,70-,71-,72-,73-,74+,75+,76-,77-,80+,81+,82+,83+,84+,85+,86-,87+,91-,92-,93+,94-,95-,96-/m1/s1
Standard InChI Key: YOHZLVCPJGMXDC-JGENGPSXSA-N
Associated Targets(Human)
AZ-521 cell line (16 Activities)
HL-60 (67320 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
SK-BR-3 (5175 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
A549 (127892 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
WI-38 (2654 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
B16-F10 (4610 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 1996.25 | Molecular Weight (Monoisotopic): 1994.9864 | AlogP: | #Rotatable Bonds: |
| Polar Surface Area: | Molecular Species: | HBA: | HBD: |
| #RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
| Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
References
| 1. Zhang J, Akihisa T, Kurita M, Kikuchi T, Zhu WF, Ye F, Dong ZH, Liu WY, Feng F, Xu J.. (2018) Melanogenesis-Inhibitory and Cytotoxic Activities of Triterpene Glycoside Constituents from the Bark of Albizia procera., 81 (12): [PMID:30520635] [10.1021/acs.jnatprod.8b00167] |
Source
Source(1):